VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,619,306 | -7.4% | 3,627,622 | +3.6% | 0.03% | -3.4% |
| Q2 2023 | $105,459,084 | -21.9% | 3,502,460 | -16.1% | 0.03% | -25.6% |
| Q1 2023 | $135,004,801 | +25.7% | 4,173,254 | +11.3% | 0.04% | +21.9% |
| Q4 2022 | $107,415,550 | +16.2% | 3,747,926 | -2.2% | 0.03% | +6.7% |
| Q3 2022 | $92,401,000 | -23.8% | 3,830,830 | -13.5% | 0.03% | -21.1% |
| Q2 2022 | $121,250,000 | -31.5% | 4,428,375 | -4.0% | 0.04% | -15.6% |
| Q1 2022 | $176,959,000 | +25.4% | 4,614,316 | +4.7% | 0.04% | +28.6% |
| Q4 2021 | $141,133,000 | +6.5% | 4,406,244 | -2.0% | 0.04% | +20.7% |
| Q3 2021 | $132,535,000 | -12.5% | 4,497,269 | +0.9% | 0.03% | -12.1% |
| Q2 2021 | $151,403,000 | +2.0% | 4,455,664 | -2.4% | 0.03% | 0.0% |
| Q1 2021 | $148,399,000 | -6.1% | 4,566,134 | -1.3% | 0.03% | -13.2% |
| Q4 2020 | $158,105,000 | -6.8% | 4,626,483 | -1.6% | 0.04% | -19.1% |
| Q3 2020 | $169,583,000 | +11.5% | 4,699,368 | +3.1% | 0.05% | +6.8% |
| Q2 2020 | $152,098,000 | +117.7% | 4,557,327 | +9.8% | 0.04% | +83.3% |
| Q1 2020 | $69,879,000 | -25.7% | 4,149,509 | +12.1% | 0.02% | -4.0% |
| Q4 2019 | $94,054,000 | -73.3% | 3,701,947 | -72.8% | 0.02% | -75.0% |
| Q3 2019 | $352,054,000 | +8.8% | 13,607,686 | +4.7% | 0.10% | +8.7% |
| Q2 2019 | $323,702,000 | +478.0% | 12,992,145 | +356.8% | 0.09% | +441.2% |
| Q1 2019 | $56,002,000 | -43.1% | 2,844,258 | -43.8% | 0.02% | -48.5% |
| Q4 2018 | $98,403,000 | -59.2% | 5,063,070 | -62.7% | 0.03% | -51.5% |
| Q3 2018 | $240,991,000 | +450.5% | 13,568,272 | +501.6% | 0.07% | +423.1% |
| Q2 2018 | $43,779,000 | -51.3% | 2,255,472 | -47.4% | 0.01% | -51.9% |
| Q1 2018 | $89,970,000 | +91.1% | 4,290,321 | +58.3% | 0.03% | +107.7% |
| Q4 2017 | $47,080,000 | -24.8% | 2,709,767 | -20.4% | 0.01% | -31.6% |
| Q3 2017 | $62,629,000 | -87.0% | 3,404,413 | -84.6% | 0.02% | -87.7% |
| Q2 2017 | $483,290,000 | -24.1% | 22,161,523 | -21.6% | 0.16% | -25.1% |
| Q1 2017 | $636,550,000 | +80.7% | 28,271,118 | +59.8% | 0.21% | +66.9% |
| Q4 2016 | $352,238,000 | +353.2% | 17,690,158 | +373.6% | 0.12% | +327.6% |
| Q3 2016 | $77,722,000 | -73.1% | 3,735,091 | -64.9% | 0.03% | -73.9% |
| Q2 2016 | $288,988,000 | – | 10,633,047 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |